NASDAQ:ADUS Addus HomeCare (ADUS) Stock Price, News & Analysis $96.83 -0.03 (-0.03%) Closing price 06/26/2026 03:59 PM EasternExtended Trading$96.94 +0.11 (+0.11%) As of 06/26/2026 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Addus HomeCare Stock (NASDAQ:ADUS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Addus HomeCare alerts:Sign Up Key Stats Today's Range$95.67▼$98.3350-Day Range$88.49▼$99.5752-Week Range$87.95▼$124.43Volume813,759 shsAverage Volume201,303 shsMarket Capitalization$1.81 billionP/E Ratio17.90Dividend YieldN/APrice Target$131.00Consensus RatingModerate Buy Company Overview Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life. The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists. Addus HomeCare also provides private duty nursing, hospice and palliative care, and specialized programs for chronic conditions, Alzheimer’s disease, and pediatric therapy needs. Telehealth solutions and care coordination tools are integrated to enhance clinical oversight and patient engagement. Tracing its roots to operations established in 1970, Addus HomeCare has grown through strategic acquisitions and organic expansion to serve clients in approximately 30 states. Headquartered in Charlotte, North Carolina, the company leverages a veteran executive leadership team with deep expertise in home health care delivery, regulatory compliance, and operational excellence. Addus HomeCare remains committed to advancing community-based services that enable individuals to “age in place” with dignity and comfort.AI Generated. May Contain Errors. Read More Addus HomeCare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreADUS MarketRank™: Addus HomeCare scored higher than 89% of companies evaluated by MarketBeat, and ranked 63rd out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingModerate Buy Consensus RatingAddus HomeCare has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 1 strong buy rating, 6 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialAddus HomeCare has a consensus price target of $131.00, representing about 35.3% upside from its current price of $96.83.Amount of Analyst CoverageAddus HomeCare has only been the subject of 3 research reports in the past 90 days.Read more about Addus HomeCare's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.81% Earnings GrowthEarnings for Addus HomeCare are expected to grow by 8.81% in the coming year, from $6.24 to $6.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 17.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.22.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 17.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.90.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 1.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Addus HomeCare's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.18% of the float of Addus HomeCare has been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 4.52.Change versus previous monthShort interest in Addus HomeCare has recently decreased by 3.63%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. News and Social Media3.8 / 5News Sentiment1.12 News SentimentAddus HomeCare has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Addus HomeCare this week, compared to 4 articles on an average week.Search Interest2 people have searched for ADUS on MarketBeat in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $90,168.00 in company stock.Percentage Held by Insiders4.10% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions95.35% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Addus HomeCare's insider trading history. Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADUS Stock News HeadlinesAddus HomeCare (NASDAQ:ADUS) Insider Heather Brianne Dixon Sells 288 SharesJune 24 at 5:36 AM | insidertrades.comAddus Homecare (ADUS) Receives a Buy from TD CowenJune 19, 2026 | theglobeandmail.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.June 27 at 1:00 AM | Profits Run (Ad)Assessing Addus HomeCare (ADUS) Valuation After Recent Share Price WeaknessMay 25, 2026 | finance.yahoo.comAddus HomeCare: Strong Position Amid An Opportunistic MarketMay 23, 2026 | seekingalpha.comBridge City Nearly Tripled Its Addus Position — Into a Down StockMay 20, 2026 | theglobeandmail.comAddus HomeCare Delivers Growth, Margin Gains in Q1May 19, 2026 | tipranks.comAddus HomeCare says license moratorium won't slow personal care growth, M&AMay 19, 2026 | msn.comSee More Headlines ADUS Stock Analysis - Frequently Asked Questions How have ADUS shares performed this year? Addus HomeCare's stock was trading at $107.39 at the beginning of 2026. Since then, ADUS stock has decreased by 9.8% and is now trading at $96.83. How were Addus HomeCare's earnings last quarter? Addus HomeCare Corporation (NASDAQ:ADUS) released its quarterly earnings data on Monday, May, 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare's revenue was up 7.7% compared to the same quarter last year. Read the conference call transcript. When did Addus HomeCare IPO? Addus HomeCare (ADUS) raised $65 million in an initial public offering (IPO) on Thursday, October 22nd 2009. The company issued 5,400,000 shares at $11.00-$13.00 per share. Who are Addus HomeCare's major shareholders? Top institutional shareholders of Addus HomeCare include Wasatch Advisors LP (4.66%), Dimensional Fund Advisors LP (3.99%), Principal Financial Group Inc. (2.33%) and Bank of America Corp DE (1.73%). Insiders that own company stock include R Dirk Allison, Brian Poff, Darby Anderson, Heather Brianne Dixon, W Bradley Bickham, Sean Gaffney, Roberton James Stevenson, Monica Raines, Cliff Donald Blessing, David W Tucker, Michael D Wattenbarger, Veronica Hill-Milbourne and Esteban Lopez. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Addus HomeCare investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), Eli Lilly and Company (LLY) and ServiceNow (NOW). Company Calendar Last Earnings5/04/2026Today6/27/2026Next Earnings (Estimated)8/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 ADUS's financial health is in the Red zone, according to TradeSmith. ADUS has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:ADUS CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees50,659Year Founded1979Price Target and Rating Average Price Target for Addus HomeCare$131.00 High Price Target$145.00 Low Price Target$92.00 Potential Upside/Downside+35.3%Consensus RatingModerate Buy Rating Score (0-4)2.70 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$5.41 Trailing P/E Ratio17.90 Forward P/E Ratio15.52 P/E Growth1.33Net Income$95.91 million Net Margins6.89% Pretax Margin9.17% Return on Equity9.80% Return on Assets7.34% Debt Debt-to-Equity Ratio0.08 Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$1.42 billion Price / Sales1.27 Cash Flow$6.49 per share Price / Cash Flow14.91 Book Value$58.72 per share Price / Book1.65Miscellaneous Outstanding Shares18,670,000Free Float17,900,000Market Cap$1.81 billion OptionableOptionable Beta0.89 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:ADUS) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
